CellPly
3 known investors
Cellply develops VivaCyte, an automated analytical platform for characterizing immune cells at single-cell resolution, used in the discovery and process development of cell therapies. The system handles sample preparation through image processing, analyzing over 100 samples per run and more than 1,000 single cells per sample.
BiotechDeep TechMedical Devices
Investors · 3
In the news
Frequently asked questions
- What does CellPly do?
- Cellply develops VivaCyte, an automated analytical platform for characterizing immune cells at single-cell resolution, used in the discovery and process development of cell therapies. The system handles sample preparation through image processing, analyzing over 100 samples per run and more than 1,000 single cells per sample.
- Who are CellPly's investors?
- CellPly's investors include Indaco Venture Partners, Italian Angels for Growth, LIFTT.